InvestorsHub Logo
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

Re: biopharm post# 248277

Friday, 01/08/2016 6:07:23 PM

Friday, January 08, 2016 6:07:23 PM

Post# of 346073
BIO Yes the strategy is very clear but patients is wearing thin for some investors. The process takes time from lab to market on Bavi. We had a bump in the road back in 2012 but forging ahead now!



Create labeling strategies and implement new/revised labeling and support documentation for submissions.
• Possess a strong working knowledge of FDA regulations and guidance on ALP and apply understanding to business situations in the immuno-oncology field.
• Review labeling, advertising, promotional and other related materials for Peregrine's immuno-oncology products to ensure compliance with applicable FDA laws, regulations and guidance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News